» Articles » PMID: 18779307

Liver As a Key Organ in the Supply, Storage, and Excretion of Copper

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2008 Sep 10
PMID 18779307
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The liver plays an important role in the disposition of copper. Most dietary copper passes through the liver where it can be used for protein and energy production or excreted through the biliary route. Because copper is a prooxidant, its intracellular handling is tightly managed. In Wilson disease, in which synthesis of ceruloplasmin and biliary excretion of copper are defective, copper accumulates in the liver and leads to progressive liver damage. The features of hepatic Wilson disease are highly variable. The spectrum of liver disease includes mild inflammation, fatty liver, an autoimmune disorder, and cirrhosis. Wilson disease thus resembles drug hepatotoxicity, and indeed it can be regarded as a prototypic example of endogenous hepatotoxicity. Biomarkers developed for detecting drug hepatotoxicity may be relevant to Wilson disease. Biomarkers developed through metalloproteomics, which for copper seeks to define a set of proteins that have copper-binding capacity, or through genomic studies may also be relevant to Wilson disease and other disorders of copper handling, whether copper is deficient or overloaded.

Citing Articles

Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model.

Abdeen A, Trist B, Nikseresht S, Harwood R, Roudeau S, Rowlands B Acta Neuropathol. 2025; 149(1):22.

PMID: 40042537 PMC: 11882636. DOI: 10.1007/s00401-025-02859-6.


Detection of reproducible liver cancer specific ligand-receptor signaling in blood.

Safrastyan A, Wollny D Front Bioinform. 2025; 4():1332782.

PMID: 39850635 PMC: 11754192. DOI: 10.3389/fbinf.2024.1332782.


Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.

Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S Mol Cancer. 2024; 23(1):255.

PMID: 39543600 PMC: 11566504. DOI: 10.1186/s12943-024-02130-8.


Deciphering the Role of Copper Homeostasis in Atherosclerosis: From Molecular Mechanisms to Therapeutic Targets.

Lv X, Zhao L, Song Y, Chen W, Tuo Q Int J Mol Sci. 2024; 25(21).

PMID: 39519014 PMC: 11546650. DOI: 10.3390/ijms252111462.


Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy.

Zhang S, Huang Q, Ji T, Li Q, Hu C Biomark Res. 2024; 12(1):130.

PMID: 39482784 PMC: 11529036. DOI: 10.1186/s40364-024-00677-8.